Jacobi J et al. Utilization of research knowledge in sustainable development pathways: Insights from a transdisciplinary research-for-development programme. Environ Sci Policy. 2020;103:21-29. DOI: 10.1016/j.envsci.2019.10.003

Nhung N.T.T et al. Exposure to air pollution and risk of hospitalization for cardiovascular diseases amongst Vietnamese adults: case-crossover study. Sci Total Environ. 2020;703:134637. DOI: 10.1016/j.scitotenv.2019.134637

Pelikan K, Jeffrey R, Roelcke T. The time where the British took the lead is over” - ethical aspects of writing in complex research partnerships. Res Ethics. 2020(in press)

Tasdemir D et al. Antiprotozoal and antihelminthic properties of plants ingested by wild Japanese macaques (Macaca fuscata yakui) in Yakushima Island. J Ethnopharmacol. 2020;247:112270. DOI: 10.1016/j.jep.2019.112270

Abidi S.K et al. An individual patient data meta-analysis to estimate the diagnostic accuracy of a machine learning-based software for analyzing chest x-rays of persons with symptoms of pulmonary tuberculosis: preliminary findings. Am J Respir Crit Care Med, 2019;199:A5167

Ackermann-Liebrich U, Felber Dietrich D, Kutlar Joss M. Respiratory and cardiovascular effects of NO2. Reference Module in Earth Systems and Environmental Sciences, 1-10. Amsterdam: Elsevier, 2019. DOI: 10.1016/B978-0-12-409548-9.02128-X

Ahoua A.R.C et al. Anti-inflammatory and quinone reductase-inducing compounds from Beilschmiedia mannii. Planta Med. 2019;85(5):379-384. DOI: 10.1055/a-0798-3155

Alam M.M et al. Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target. Science. 2019;365(6456):eaau1682. DOI: 10.1126/science.aau1682

Alasad S.M.S, Salih O.A.M, Hassan M. Insight into potassium's role in childhood mortality due to severe acute malnutrition. Sudan J Paediatr. 2019;19(1):44-51. DOI: 10.24911/SJP.106-1513711620

Albertini B et al. Combining mechanochemistry and spray congealing for new praziquantel pediatric formulations in schistosomiasis treatment. Int J Mol Sci. 2019;20(5):1233. DOI: 10.3390/ijms20051233

Our research

We developed a brad research portfolio comprising clinical, field and laboratory studies.

The goals of our research are to

  • improve understanding of the pathogenesis, immunology and transmission of Buruli ulcer,
  • develop methods for early diagnosis, and
  • investigate prospects for improving therapy and vaccine development.

Symptoms and Treatment

Mycolactone is believed to play a central role in determining the extracellular localization of the bacteria and modulation of immunological responses to M. ulcerans. Clinical lesions usually start as painless nodules and if left untreated lead to massive destruction of skin and sometimes bone. While surgery has traditionally been the only recommended treatment for BU, in 2004 WHO published provisional guidelines recommending treatment with a combination of rifampicin and streptomycin for 8 weeks.

Mycobacterium Ulcerans Infection (Buruli ulcer): Towards Improving Control, Diagnosis and Therapy

After tuberculosis and leprosy, Buruli ulcer (BU), caused by M. ulcerans, is the third most common mycobacterial disease, and Western Africa is the world region most affected by this chronic necrotising disease of the skin and the subcutaneous tissue. M. ulcerans is unique among mycobacterial pathogens in that it is mainly extracellular and produces a plasmid-encoded toxin with a polyketide-derived macrolide structure, named mycolactone.

Buruli ulcer